BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10739671)

  • 1. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.
    Manzella L; Gualdi R; Perrotti D; Nicolaides NC; Girlando G; Giuffrida MA; Messina A; Calabretta B
    Exp Cell Res; 2000 Apr; 256(1):248-56. PubMed ID: 10739671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma.
    Yuan W; Yufit T; Li L; Mori Y; Chen SJ; Varga J
    J Cell Physiol; 1999 Apr; 179(1):97-108. PubMed ID: 10082137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
    Nguyen H; Mustafa A; Hiscott J; Lin R
    Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
    Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
    J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro.
    Zhang S; Thomas K; Blanco JC; Salkowski CA; Vogel SN
    J Endotoxin Res; 2002; 8(5):379-88. PubMed ID: 12537697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation.
    Wang LG; Liu XM; Li ZR; Denstman S; Bloch A
    Cell Growth Differ; 1994 Nov; 5(11):1243-51. PubMed ID: 7848925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
    Lee AH; Hong JH; Seo YS
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
    Mountz JD; Steinberg AD
    J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.
    Xi H; Eason DD; Ghosh D; Dovhey S; Wright KL; Blanck G
    Oncogene; 1999 Oct; 18(43):5889-903. PubMed ID: 10557076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation.
    Nguyen H; Teskey L; Lin R; Hiscott J
    Oncogene; 1999 Sep; 18(39):5455-63. PubMed ID: 10498899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
    Bartůnek P; Králová J; Blendinger G; Dvorák M; Zenke M
    Oncogene; 2003 Apr; 22(13):1927-35. PubMed ID: 12673198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2.
    Vaughan PS; Aziz F; van Wijnen AJ; Wu S; Harada H; Taniguchi T; Soprano KJ; Stein JL; Stein GS
    Nature; 1995 Sep; 377(6547):362-5. PubMed ID: 7566094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription.
    Morin P; Bragança J; Bandu MT; Lin R; Hiscott J; Doly J; Civas A
    J Mol Biol; 2002 Mar; 316(5):1009-22. PubMed ID: 11884139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
    Nakagoshi H; Kanei-Ishii C; Sawazaki T; Mizuguchi G; Ishii S
    Oncogene; 1992 Jun; 7(6):1233-40. PubMed ID: 1594249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory transcription factors are constitutively expressed and spatially regulated in the mouse lens.
    Li W; Nagineni CN; Efiok B; Chepelinsky AB; Egwuagu CE
    Dev Biol; 1999 Jun; 210(1):44-55. PubMed ID: 10364426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
    Burysek L; Yeow WS; Pitha PM
    J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation in megakaryocytes: the thrombopoietin receptor gene as a model.
    Mignotte V; Deveaux S; Filipe A
    Stem Cells; 1996; 14 Suppl 1():232-9. PubMed ID: 11012226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.